Seven Fleet Capital Management LP
An institutional investment manager in MOUNTAIN VIEW, CA. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 17, 2026. SEC CIK 2092021.
- Reported value$605.9m
- Positions96
Holdings: 96 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31. The filing's table has 114 lines; lines for the same security and option type are added together here.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| CG Oncology IncCGON | COM | 156944100 | 134 | 22.1% | 1,886,236 | Added+1,810,478 | |
| Tango Therapeutics IncTNGX | COM | 87583X109 | 95.7 | 15.8% | 3,228,144 | Added+2,726,132 | |
| Revolution Medicines IncRVMD | COM | 76155X100 | 45.3 | 7.5% | 242,029 | Added+161,237 | |
| Pharvaris N V | COM | N69605108 | 26.8 | 4.4% | 774,501 | Added+601,770 | |
| Liquidia CorporationLQDA | COM NEW | 53635D202 | 20.5 | 3.4% | 256,603 | Added+68,727 | |
| Enliven Therapeutics IncELVN | COM | 29337E102 | 18.5 | 3.1% | 365,386 | Added+201,356 | |
| Abivax SAABVX | SPONSORED ADS | 00370M103 | 14.8 | 2.4% | 111,334 | Added+68,282 | |
| Avalo Therapeutics IncAVTX | COM NEW | 05338F306 | 14.2 | 2.4% | 770,765 | Added+556,946 | |
| Mirum Pharmaceuticals IncMIRM | COM | 604749101 | 12.9 | 2.1% | 110,393 | New+110,393 | |
| Assembly Biosciences IncASMB | COM NEW | 045396207 | 11.9 | 2.0% | 433,147 | Added+377,000 | |
| Century Therapeutics IncIPSC | COM | 15673T100 | 10.7 | 1.8% | 4,347,826 | Added+1,400,000 | |
| Cytokinetics IncCYTK | COM NEW | 23282W605 | 10.1 | 1.7% | 118,240 | Added+56,971 | |
| Taysha Gene Therapies IncTSHA | COM SHS | 877619106 | 9.9 | 1.6% | 1,504,400 | Added+878,692 | |
| Veradermics IncMANE | COMMON STOCK | 922967104 | 9.8 | 1.6% | 80,000 | New+80,000 | |
| Arrivent Biopharma IncAVBP | COM | 04272N102 | 8.6 | 1.4% | 246,606 | Added+196,354 | |
| Tarsus Pharmaceuticals IncTARS | COM | 87650L103 | 7.9 | 1.3% | 117,067 | Added+97,267 | |
| Xencor IncXNCR | COM | 98401F105 | 7.8 | 1.3% | 368,305 | Added+288,305 | |
| Roivant Sciences Ltd | SHS | G76279101 | 7.8 | 1.3% | 220,126 | Added+91,958 | |
| Damora Therapeutics Inc | COM NEW | 36322Q206 | 7.4 | 1.2% | 284,430 | Added+183,182 | |
| Axsome Therapeutics IncAXSM | COM | 05464T104 | 7.1 | 1.2% | 28,826 | Added+14,771 | |
| Definium Therapeutics IncDFTX | COM SHS | 24477V105 | 7.0 | 1.2% | 148,647 | Added+48,760 | |
| Dianthus Therapeutics IncDNTH | COM | 252828108 | 6.3 | 1.0% | 64,723 | Added+10,465 | |
| Cogent Biosciences IncCOGT | COM | 19240Q201 | 5.7 | 0.9% | 147,510 | Reduced−1,889 | |
| Erasca IncERAS | COM | 29479A108 | 5.6 | 0.9% | 308,007 | Added+85,539 | |
| Protagonist Therapeutics IncPTGX | COM | 74366E102 | 5.6 | 0.9% | 45,400 | Added+41,400 | |
| Minerva Neurosciences IncNERV | COM NEW | 603380205 | 5.6 | 0.9% | 1,001,373 | Added+752,897 | |
| Editas Medicine IncEDIT | COM | 28106W103 | 4.3 | 0.7% | 1,330,500 | New+1,330,500 | |
| Cytomx Therapeutics Inc.CTMX | COM | 23284F105 | 4.1 | 0.7% | 1,085,398 | Added+714,000 | |
| Eupraxia Pharmaceuticals IncEPRX | COM | 29842P105 | 4.0 | 0.7% | 610,785 | Added+177,270 | |
| Sutro Biopharma IncSTRO | COM SHS | 869367201 | 3.8 | 0.6% | 159,118 | New+159,118 | |
| Relay Therapeutics IncRLAY | COM | 75943R102 | 3.3 | 0.6% | 178,222 | Reduced−79,516 | |
| Celldex Therapeutics Inc NewCLDX | COM NEW | 15117B202 | 3.2 | 0.5% | 86,664 | Added+57,364 | |
| Ascendis Pharma A/S | ORD SHS | K08588103 | 3.2 | 0.5% | 11,869 | New+11,869 | |
| Sagimet Biosciences IncSGMT | COM SER A | 786700104 | 3.1 | 0.5% | 403,545 | New+403,545 | |
| ZAI Lab LtdZLAB | ADR | 98887Q104 | 2.9 | 0.5% | 136,016 | Added+58,158 | |
| SAB Biotherapeutics IncSABS | COM NEW | 78397T202 | 2.9 | 0.5% | 736,077 | Added+636,077 | |
| Madrigal Pharmaceuticals IncMDGL | COM | 558868105 | 2.7 | 0.4% | 4,973 | Added+1,580 | |
| Praxis Precision Medicines IPRAX | COM NEW | 74006W207 | 2.5 | 0.4% | 7,540 | New+7,540 | |
| Relmada Therapeutics IncRLMD | COM | 75955J402 | 2.4 | 0.4% | 348,265 | New+348,265 | |
| Agios Pharmaceuticals IncAGIO | COM | 00847X104 | 2.1 | 0.3% | 56,900 | Reduced−152,647 | |
| Xenon Pharmaceuticals IncXENE | COM | 98420N105 | 2.1 | 0.3% | 33,300 | New+33,300 | |
| Savara IncSVRA | COM | 805111101 | 1.9 | 0.3% | 309,103 | Added+13,415 | |
| C4 Therapeutics IncCCCC | COM STK | 12529R107 | 1.8 | 0.3% | 381,169 | Added+324,093 | |
| Vaxcyte IncPCVX | COM | 92243G108 | 1.8 | 0.3% | 29,800 | Reduced−78,650 | |
| Celcuity IncCELC | COM | 15102K100 | 1.7 | 0.3% | 16,252 | Added+10,252 | |
| Syndax Pharmaceuticals IncSNDX | COM | 87164F105 | 1.6 | 0.3% | 77,930 | New+77,930 | |
| Zentalis Pharmaceuticals IncZNTL | COM | 98943L107 | 1.5 | 0.2% | 317,600 | Added+207,600 | |
| Structure Therapeutics IncGPCR | SPONSORED ADS | 86366E106 | 1.4 | 0.2% | 26,800 | Added+17,800 | |
| Leonabio IncLONA | COM | 04746L203 | 1.4 | 0.2% | 154,153 | Reduced−10,523 | |
| Ideaya Biosciences IncIDYA | COM | 45166A102 | 1.4 | 0.2% | 37,865 | Reduced−48,418 | |
| Geron CorpGERN | COM | 374163103 | 1.4 | 0.2% | 1,057,228 | Added+633,048 | |
| Adlai Noryte LtdANL | SPONSORED ADS | 00704R109 | 1.3 | 0.2% | 113,207 | New+113,207 | |
| Corvus Pharmaceuticals IncCRVS | COM | 221015100 | 1.2 | 0.2% | 82,890 | Unchanged | |
| Alkermes plc | SHS | G01767105 | 1.2 | 0.2% | 23,285 | Reduced−885 | |
| Spyre Therapeutics IncSYRE | COM NEW | 00773J202 | 1.2 | 0.2% | 13,300 | Reduced−6,390 | |
| Perspective Therapeutics IncCATX | COM NEW | 46489V302 | 1.1 | 0.2% | 332,613 | Reduced−46,469 | |
| Onkure Therapeutics IncOKUR | COM CL A | 68277Q105 | 1.1 | 0.2% | 240,963 | New+240,963 | |
| Summit Therapeutics IncSMMT | COM | 86627T108 | 1.1 | 0.2% | 73,300 | New+73,300 | |
| AN2 Therapeutics IncANTX | COM | 037326105 | 1.0 | 0.2% | 208,946 | Added+9,245 | |
| Contineum Therapeutics IncCTNM | CL A | 21217B100 | 1.0 | 0.2% | 60,541 | Added+33,487 | |
| Trevi Therapeutics IncTRVI | COM | 89532M101 | 0.8 | 0.1% | 45,598 | Added+18,449 | |
| Voyager Therapeutics IncVYGR | COM | 92915B106 | 0.8 | 0.1% | 230,406 | Added+115,203 | |
| Inventiva SAIVA | ADS | 46124U107 | 0.8 | 0.1% | 200,141 | Unchanged | |
| Engene Therapeutics IncENGN | COM | 29286X101 | 0.7 | 0.1% | 411,065 | New+411,065 | |
| Larimar Therapeutics IncLRMR | COM | 517125100 | 0.7 | 0.1% | 230,921 | Reduced−25,664 | |
| Inhibikase Therapeutics IncIKT | COM NEW | 45719W205 | 0.7 | 0.1% | 346,900 | Added+21,300 | |
| Neurogene IncNGNE | COM | 64135M105 | 0.7 | 0.1% | 22,060 | New+22,060 | |
| Ishares TR | U.S. MED DVC ETF | 464288810 | 0.7 | 0.1% | 13,800 | New+13,800 | |
| Silence Therapeutics plcSLN | ADS | 82686Q101 | 0.7 | 0.1% | 60,107 | Reduced−96,652 | |
| Krystal Biotech IncKRYS | COM | 501147102 | 0.7 | 0.1% | 1,774 | Reduced−2,542 | |
| Opus Genetics IncIRD | COM | 67577R102 | 0.6 | <0.1% | 143,137 | Added+8,895 | |
| Palisade Bio IncPALI | COM | 696389402 | 0.6 | <0.1% | 272,204 | Added+59,104 | |
| Evolus IncEOLS | COM | 30052C107 | 0.5 | <0.1% | 78,057 | Unchanged | |
| Unicycive Therapeutics IncUNCY | COM NEW | 90466Y202 | 0.5 | <0.1% | 103,400 | Added+47,700 | |
| Compass Therapeutics IncCMPX | COM | 20454B104 | 0.5 | <0.1% | 233,066 | Reduced−283,906 | |
| Biocryst Pharmaceuticals IncBCRX | COM | 09058V103 | 0.5 | <0.1% | 51,024 | Reduced−51,469 | |
| Bright Minds Biosciences IncDRUG | COM NEW | 10919W405 | 0.4 | <0.1% | 6,395 | Unchanged | |
| Prothena Corp plc | SHS | G72800108 | 0.4 | <0.1% | 43,300 | Unchanged | |
| Monte Rosa Therapeutics IncGLUE | COM | 61225M102 | 0.4 | <0.1% | 16,800 | Reduced−5,730 | |
| Olema Pharmaceuticals IncOLMA | COM | 68062P106 | 0.4 | <0.1% | 31,476 | New+31,476 | |
| Milestone Pharmaceuticals inMIST | COM | 59935V107 | 0.4 | <0.1% | 270,233 | Reduced−63,100 | |
| Entera Bio Ltd | SHS | M40527109 | 0.3 | <0.1% | 191,354 | Reduced−14,188 | |
| CUE Biopharma IncCUE | COM | 22978P205 | 0.3 | <0.1% | 10,702 | New+10,702 | |
| MBX Biosciences IncMBX | COM | 55287L101 | 0.3 | <0.1% | 6,000 | New+6,000 | |
| Beam Therapeutics IncBEAM | COM | 07373V105 | 0.3 | <0.1% | 8,804 | Unchanged | |
| Astrazeneca plc | ORD | G0593M107 | 0.3 | <0.1% | 1,400 | New+1,400 | |
| Amylyx Pharmaceuticals IncAMLX | COM | 03237H101 | 0.3 | <0.1% | 14,540 | Reduced−2,131 | |
| Stoke Therapeutics IncSTOK | COM | 86150R107 | 0.3 | <0.1% | 7,745 | New+7,745 | |
| Viking Therapeutics IncVKTX | COM | 92686J106 | 0.3 | <0.1% | 7,404 | New+7,404 | |
| Lipocine Inc NewLPCN | COM NEW | 53630X203 | 0.2 | <0.1% | 78,842 | Reduced−46,100 | |
| Corbus Pharmaceuticals HoldingsCRBP | COM NEW | 21833P301 | 0.2 | <0.1% | 21,432 | Reduced−64,255 | |
| Promis Neurosciences IncPMN | COM SHS | 74346M505 | 0.1 | <0.1% | 10,600 | Unchanged | |
| Wave Life Sciences Ltd | SHS | Y95308105 | 0.1 | <0.1% | 19,048 | New+19,048 | |
| PMV Pharmaceuticals IncPMVP | COM | 69353Y103 | 0.1 | <0.1% | 53,569 | Reduced−9,929 | |
| Fulcrum Therapeutics IncFULC | COM | 359616109 | 0.1 | <0.1% | 18,089 | Reduced−20,011 | |
| Uniqure NV | SHS | N90064101 | 0.0 | <0.1% | 338 | New+338 |
Sold out: 42 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Apogee Therapeutics Inc | COM | 03770N101 | 0.0 | 0.0% | 0 | Sold out−1,969 | |
| Ascendis Pharma A/S | SPONSORED ADS | 04351P101 | 0.0 | 0.0% | 0 | Sold out−12,179 | |
| Avalo Therapeutics Inc | COM NEW | 05338F307 | 0.0 | 0.0% | 0 | Sold out−360,064 | |
| CG Oncology Inc | COM | 156944101 | 0.0 | 0.0% | 0 | Sold out−1,439,393 | |
| Climb Bio IncCLYM | COM | 28658R106 | 0.0 | 0.0% | 0 | Sold out−130,654 | |
| Compass Pathways plcCMPS | SPONSORED ADS | 20451W101 | 0.0 | 0.0% | 0 | Sold out−158,021 | |
| Compass Therapeutics Inc | COM | 20454B105 | 0.0 | 0.0% | 0 | Sold out−423,566 | |
| Context Therapeutics IncCNTX | COM | 21077P108 | 0.0 | 0.0% | 0 | Sold out−190,785 | |
| Cullinan Therapeutics IncCGEM | COM | 230031106 | 0.0 | 0.0% | 0 | Sold out−1,844 | |
| Cytomx Therapeutics Inc. | COM | 23284F106 | 0.0 | 0.0% | 0 | Sold out−714,000 | |
| Denali Therapeutics IncDNLI | COM | 24823R105 | 0.0 | 0.0% | 0 | Sold out−35,286 | |
| Dianthus Therapeutics Inc | COM | 252828109 | 0.0 | 0.0% | 0 | Sold out−26,551 | |
| Disc Medicine IncIRON | COM | 254604101 | 0.0 | 0.0% | 0 | Sold out−3,231 | |
| Edgewise Therapeutics IncEWTX | COM | 28036F105 | 0.0 | 0.0% | 0 | Sold out−11,701 | |
| ELI Lilly & CoLLY | COM | 532457108 | 0.0 | 0.0% | 0 | Sold out−720 | |
| Enliven Therapeutics Inc | COM | 29337E103 | 0.0 | 0.0% | 0 | Sold out−95,253 | |
| Eupraxia Pharmaceuticals Inc | COM | 29842P106 | 0.0 | 0.0% | 0 | Sold out−276,000 | |
| Inhibrx Biosciences IncINBX | COM | 45720N103 | 0.0 | 0.0% | 0 | Sold out−2,482 | |
| Intellia Therapeutics IncNTLA | COM | 45826J105 | 0.0 | 0.0% | 0 | Sold out−31,500 | |
| Kalvista Pharmaceuticals Inc | COM | 483497103 | 0.0 | 0.0% | 0 | Sold out−128,487 | |
| Liquidia Corporation | COM NEW | 53635D203 | 0.0 | 0.0% | 0 | Sold out−17,000 | |
| Macrogenics IncMGNX | COM | 556099109 | 0.0 | 0.0% | 0 | Sold out−13,387 | |
| Maze Therapeutics IncMAZE | COM | 578784100 | 0.0 | 0.0% | 0 | Sold out−30,707 | |
| Mineralys Therapeutics IncMLYS | COM | 603170101 | 0.0 | 0.0% | 0 | Sold out−69,571 | |
| Minerva Neurosciences Inc | COM NEW | 603380206 | 0.0 | 0.0% | 0 | Sold out−889,254 | |
| Nektar TherapeuticsNKTR | COM NEW | 640268306 | 0.0 | 0.0% | 0 | Sold out−4,300 | |
| Nuvalent NC | COM | 670703107 | 0.0 | 0.0% | 0 | Sold out−2,072 | |
| Ocular Therapeutix IncOCUL | COM | 67576A100 | 0.0 | 0.0% | 0 | Sold out−31,296 | |
| Pepgen IncPEPG | COM | 713317105 | 0.0 | 0.0% | 0 | Sold out−59,500 | |
| Pharvaris N V | COM | N69605109 | 0.0 | 0.0% | 0 | Sold out−143,966 | |
| Replimune Group IncREPL | COM | 76029N106 | 0.0 | 0.0% | 0 | Sold out−120,400 | |
| SAB Biotherapeutics Inc | COM NEW | 78397T203 | 0.0 | 0.0% | 0 | Sold out−400,000 | |
| Septerna IncSEPN | COM | 81734D104 | 0.0 | 0.0% | 0 | Sold out−11,445 | |
| Soleno Therapeutics Inc | COM | 834203310 | 0.0 | 0.0% | 0 | Sold out−54,000 | |
| Soleno Therapeutics Inc | COM | 834203309 | 0.0 | 0.0% | 0 | Sold out−115,770 | |
| Tango Therapeutics Inc | COM | 87583X110 | 0.0 | 0.0% | 0 | Sold out−300,648 | |
| Tyra Biosciences IncTYRA | COM | 90240B106 | 0.0 | 0.0% | 0 | Sold out−195,685 | |
| Tyra Biosciences Inc | COM | 90240B107 | 0.0 | 0.0% | 0 | Sold out−2,900 | |
| United Therapeutics RP DelUTHR | COM | 91307C102 | 0.0 | 0.0% | 0 | Sold out−1,128 | |
| Vaxcyte Inc | COM | 92243G109 | 0.0 | 0.0% | 0 | Sold out−20,000 | |
| Verastem IncVSTM | COM NEW | 92337C203 | 0.0 | 0.0% | 0 | Sold out−123,400 | |
| Whitehawk Therapeutics IncWHWK | COM | 00032Q104 | 0.0 | 0.0% | 0 | Sold out−54,296 |
Source: SEC EDGAR, Form 13F-HR, accession 0001013594-26-000921 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.